NasdaqGM:VCELBiotechs
How Investors Are Reacting To Vericel (VCEL) Reaffirming MACI Revenue Growth and Gross Margin Targets
Vericel Corporation recently announced its second quarter 2025 results, reporting revenue of US$63.24 million, an increase from US$52.66 million a year earlier, alongside a reduced net loss of US$553,000 and reaffirmed full-year guidance targeting MACI revenue growth and a 74% gross margin.
The combination of rising revenue and reaffirmation of profitability outlook signals management's confidence in sustaining operational improvements, despite a higher net loss year-to-date.
We'll examine...